BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Merrion Pharmaceuticals, Inc. 



Wilmington  North Carolina    U.S.A.
Phone: 910-799-1847 Fax:


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
Merrion Pharmaceuticals, Inc. to Cut 20 Dublin Jobs 9/2/2011 8:07:24 AM    More...
Merrion Pharmaceuticals, Inc. and Novo Nordisk A/S (NVO) Sign EUR 1.5M Deal for Oral Formulation Technology 12/22/2010 8:10:16 AM    More...
Merrion Pharmaceuticals, Inc. Signs Feasibility and Option Agreement for 3 Drugs With International 'Top Ten' Pharmaceutical Company 12/6/2010 11:07:49 AM    More...
Merrion Pharmaceuticals, Inc. Announces Commencement of Feasibility and Option Agreement With Rebel Pharmaceuticals 11/23/2010 11:20:48 AM    More...
Merrion Pharmaceuticals, Inc. Finalises Its Phase III Development Program for Orazol(TM) in the USA 11/16/2010 9:40:59 AM    More...
Merrion Pharmaceuticals, Inc. is Issued a Key U.S. Patent for Orazol(TM), Their Lead Product to Treat Bone Metastases Associated With Prostate, Breast and Other Cancers 5/7/2010 9:52:26 AM    More...
Merrion Pharmaceuticals, Inc. is Issued a Key United States Patent 3/2/2010 8:33:46 AM    More...
Novo Nordisk A/S (NVO) Starts Phase 1 Trial With Oral Insulin Analogue -- Merrion Pharmaceuticals, Inc. Earns USD 2 Million Milestone Payment 12/7/2009 8:52:18 AM    More...
Merrion Pharmaceuticals, Inc. Announces Preliminary Results On Phase II Orazol(tm) Study 5/15/2009 9:45:09 AM    More...
Merrion Pharmaceuticals, Inc. Announces License Agreement With Novo Nordisk A/S (NVO) to Develop Oral Formulation of GLP-1 Receptor Agonist(s) -- Novo Nordisk Makes Equity Investment in Merrion 1/16/2009 7:05:03 AM    More...
123

//-->